PROFESSSOR JEAN-PIERRE PELLETIER, M.D. is Professor of Medicine, Accredited Member of the Department of Pharmacology, Director and Co-founder of the Osteoarthritis Research Unit at the University of Montreal Hospital Centre (CHUM). The Osteoarthritis Research Unit is one of the most highly renowned and respected facilities of its kind. He is also co-titular head of the Chair in Osteoarthritis at the University of Montreal.Professor Pelletier is an internationally renowned and respected expert in the field of osteoarthritis. His principal research interest lies in understanding the mechanisms involved in the pathophysiology of osteoarthritis in humans and preclinical models, as well as in investigating and developing new therapeutic strategies to counteract the disease through basic and clinical research. He also developed, with his team, new automated magnetic resonance imaging systems for the quantification of knee and hip structural alterations in humans and animals and uses these methodologies in clinical trials. His work in the field of arthritis research has led to a large number of landmark studies and in turn to major breakthroughs and discoveries with regard to the pathophysiology and treatment of musculoskeletal diseases.Winner of several international and national awards and prizes including the Roger Demers award in 2012 and the prestigious King Faisal International Prize for Medicine in 2010. He was inducted as a “Master” of the American College of Rheumatology (ACR) in 2014 and appointed “fellow” by the Canadian Academy of Health Sciences (CAHS) in 2008. The success of his work is also illustrated by the impressive number of publications, over 485, and abstracts (more than 870) in world-renowned, peer-reviewed journals, and numerous guest speaker appearances.
Prof. Bernard Combe is Professor of Rheumatology at Montpellier University, France, and Head of the Bone and Joint Department at Montpellier University Hospital.
He completed his medical education at Montpellier University and was subsequently awarded a research fellowship in clinical immunology at the University of Texas, San Antonio, USA.
Prof. Combe was elected member of the National Board of Universities (Rheumatology) from 1994–2000 and again from 2006, as well as being president from 2010–2013. He is an active member of numerous EULAR and ACR task forces. Prof. Combe is Editor-in-Chief of RMD Open (EULAR / BMJ journal) and of La Lettre du Rhumatologue. In addition, he is a member of the editorial boards of Annals of Rheumatic Diseases, Arthritis and Rheumatism and Joint Bone Spine. Prof. Combe has co-authored more than 315 articles published in international
peer-reviewed journals, and has been a coordinator or main investigator in 131 clinical trials.
Prof. JOHANNE MARTEL-PELLETIER, Ph.D. is Professor of Medicine in the Department of Medicine and Accredited Member of the Department of Pharmacology at the University of Montreal. In 1981, she co-founded with Professor Jean-Pierre Pelletier, the Osteoarthritis Research Unit at the University of Montreal Hospital Centre, which today is world renowned for its research in the field. In 2000, they initiated a University Chair in Osteoarthritis at the University of Montreal and have been appointed titular heads of this Chair.Her research interests lie in the mechanisms involved in the etiology of osteoarthritis, such as joint tissue catabolism and cartilage repair, the molecular and biochemical mechanisms involved during the osteoarthritis process of certain proteases, pro- and anti-inflammatory factors, and growth factors in humans and targeting new therapeutic strategies for the treatment of osteoarthritis. In addition, she is involved in developing systems using magnetic resonance imaging technology for the automatic quantification of structural tissue changes in the human knee and hip.She is an active member of several editorial boards and committees and is a highly respected reviewer for numerous rheumatology and connective tissue journals and governmental and private research funding agencies at national and international levels. She has authored more than 410 publications including journal articles, reviews and book chapters and over 730 abstracts, as well as being guest editor of several journals and editor of four books. In addition, she has been an invited guest speaker at numerous national and international meetings and conferences. She is recipient of several distinguished scientific awards honouring her excellence and outstanding achievements in osteoarthritis research.
Prof. Boulos Haraoui, MD FRCPC is an Associate Professor of Medicine at the Université de Montréal and head of the Clinical Research Unit in Rheumatology at the Centre hospitalier de l’Université de Montréal (CHUM) and the Institut de rhumatologie de Montréal.
Dr Haraoui received his medical degree from St. Joseph University in Beirut, Lebanon. Following his post graduate training in Internal Medicine and Rheumatology at the University of Montreal, he completed a research Fellowship at the Arthritis Branch of the National Institutes of Health in Bethesda, Maryland.
He is a founding member and vice-chairman of the Canadian Rheumatology Research Consortium (CRRC). He also chairs the Canadian Initiative in Outcomes in Rheumatology Care (CIORA), the research granting committee of the CRA
Doctor Haraoui is a Past-Chairman of the Scientific Committee of the Canadian Rheumatology Association.
He was an examiner for the Royal College of Physicians and Surgeons of Canada and a member of the Subspecialty Committee on Rheumatology of the RCPSC. He is also a past chairman of the Laurentian Conference of Rheumatology
Doctor Haraoui serves on several provincial, national and international educational and advisory committees, especially on issues pertaining to the diagnosis and management of rheumatoid arthritis.
Dr. Jordi Monfort Faure Graduated in Medicine at the Universitat Central de Barcelona, Specialty Registrar of Rheumatology, Parc de Salut Mar. Hospital del Mar Barcelona, Master in Biomedical Sciences, Université de Montréal, Profeciency University of McGill. Montreal, Master in hospital management International University of Catalonia, PhD, Universitat Autonòma de Barcelona 2010-2013
He is currently an Associated Professor of Rheumatology Universitat Autònoma de Barcelona
Tore K. Kvien, MD, PhD has been head of the Department of Rheumatology at Diakonhjemmet Hospital, Oslo, Norway since 1994 and professor of rheumatology at the University of Oslo since 1997. Throughout his career, Professor Kvien has made major contributions to the development and validation of important tools for the assessment of rheumatic diseases (patient-reported outcomes, clinical measures and tools based on imaging modalities).
Professor Kvien has been author on about 500 peer-reviewed publications. He has been editor-in-chief of Annals of Rheumatic Diseases since 2008, was president of the European League Against Rheumatism (EULAR) from 2005 to 2007 and has been the principle investigator of the Norwegian government financed biosimilar switching study (NOR-SWITCH).
Lee S. Simon, MD, FACP, FACR
Principal, SDG LLC
Dr. Simon is a Rheumatologist and has been the Division Director of Analgesic, Anti-inflammatory and Ophthalmologic Drug Products, FDA. He is presently a Principal in SDG LLC, a consulting firm helping companies to create successful drug development programs through good designs and using insightful regulatory strategy.
He has been a clinical Rheumatologist for 30 years. He is a fellow of the American College of Physicians (1991) and the American College of Rheumatology (1986). He has served two terms on the Board of Directors of the American College of Rheumatology, served as the Chair of Education for the ACR. He has served as the Scientific Abstract Selection Chair. He was awarded the 2003 Distinguished Service Award of the ACR and was awarded the 2003 Scientific Leadership Award of the Lupus Research Institute He is on the Steering Committee of OMERACT (Outcome Measures in Rheumatology) Biannual Meeting. He was an Associate Professor of Medicine at Harvard Medical School.
Wen-Chan Tsai is chief of Rheumatology at the Kaohsiung Medical University Hospital, Taiwan, director of department of laboratory medicine at Kaohsiung Medical University Hospital in Kaohsiung, Taiwan and also secretary general of Asia Pacific League of Associations for Rheumatology (APLAR).
Dr Tsai obtained his medical degree in 1982 from the Kaohsiung Medical University, Taiwan. Subsequently, he underwent residency training in the same institute to become a specialist in internal medicine in 1989 and specialist in rheumatology in 1991. He also earned a PhD in in 2002 from the University of Medical Research, Kaohsiung Medical University, Taiwan. From 1996 to 1997, Dr Tsai underwent post-doctoral fellowship training at the Department of Rheumatology of the University of California, Los Angeles (UCLA), USA.
From 2003 to 2009, Dr Tsai served as Chief of Rheumatology at the Kaohsiung Medical University Hospital, Taiwan. During that period, he also served as Director of Resident Affairs (until 2007) and, subsequently, as Deputy Director of the Department of Medicine, the Kaohsiung Medical University, Taiwan. From 2007 to 2008, Dr Tsai held the position of Director of Molecular and Cellular Function in Laboratory Medicine at the same institute. In 2009, he became Deputy Superintendent of the Kaohsiung Municipal Ta-Tung Hospital, Taiwan, and has held this position until the present. In 2012, he served as director of department of laboratory medicine and chief of clinical trial center at Kaohsiung Medical University Hospital. In 2015, he also served as chief of rheumatology at Kaohsiung Medical University Hospital. In 2016, he also served as secretary general of APLAR.
Scientific Program Committee
Dr Waleed Yousef AlShehhi
Dr. AlShehhi studied and trained in Ireland between 1987 till 2005. He graduated from the Royal College of Surgeon’s in Ireland in 1995, he then finished rheumatology training in 2005 in Saint Vincent’s Hospital Ireland. He was then a consultant rheumatologist in Zayed Military hospital until Jan 2007. In addition, he was also consultant rheumatologist in AlQassimi hospital Sharjah and Saif hospital RasAlKhaimah untill Sept 2010 (public sector).
Currently, Dr. AlShehhi is a Consultant rheumatologist in Dr. Sulaiman AlHabib (private) Medical Centre Dubai health care city since 2009 to date. Dr. AlShehhi is an accredited EULAR trainer in musculoskeletal ultrasound and an Examiner for the RCPI- Ireland. He also worked as a lecturer in Sharjah Medical University. He is the Founder and two times president of the Emirates society for rheumatology (ESR) and the Chairman for the Asia Pacific League against rheumatism (APLAR) in Dubai 2017. He is a fellow of the American college for rheumatology. He has recently chaired the ACR- ESR meeting in Dubai in collaboration with the American College of Rheumatology. Dr Waleed was recently elected as the Secretary General for Arabic League against Rheumatism (ARLAR).
Dr. AlShehhi, father of 6, has chaired and presented at over 200 different national, regional and international rheumatology meetings. He has been awarded the best Physician in UAE 2014. He has a number of publications in both RA and PsA. His main area of interest is Spondyloarthritis, Biosimilars and MSK- US.
Professor Chang Chi-Chen, MD and PhD, Taipei Medical University, is a rheumatologist. He is Head of the Department of Rheumatology in Taipei Medical University Hospital. His research interests are in the ultrasound in rheumatic diseases. He serves on the editorial boards of IJRD and is the Secretary General of APLAR. He is also the boards of Director of Taiwan Rheumatology Association.
After completion of my Medical Graduation (M.B.B.S) from Puducherry, Post-Graduation (M.D) in Internal Medicine from GSVM Medical College, Kanpur and 3 year Post-Doctoral degree (DM) in Clinical Immunology from SGPGIMS, Lucknow, I joined as a faculty at Christian Medical College Hospital, Vellore. I then availed 3 years advanced training in rheumatology at teaching hospital of Adelaide, South Australia, namely, The Royal Adelaide Hospital, The Queen Elizabeth Hospital, Flinders Medical Centre And The Repatriation Hospital, Adelaide.I single handedly established the Department of Clinical Immunology And Rheumatology at CMC, Vellore, with out-patient, in-patient, consultations, procedures, teaching programmes, research facilities, creation of faculty positions, Basic Scientist post and technicians position. I also created the infrastructure and services of the most comprehensive laboratory facilities for all autoimmune rheumatic diseases. Ours is among the handful of centres in the country with dedicated extremity MRI machine, ultrsonography, nailfold capillaroscopy, real time PCR and several other advanced techniques available within the department. I have one of the largest cohorts in the world, of systemic autoimmune diseases including > 600 patients of takayasu arteritis and primary sjogren’s syndrome each. The department has cohorts of > 10000 each of rheumatoid arthritis and spondyloarthritis and > 6000 patients with lupus. We have contributed the largest number of patients of takayasu arteritis in the DCVAS-ACR-EULAR database for classification of vasculitis as well as 302 patients in the sjogren’s big data group. The department sees approximately 60000 patients every year as out-patients and approximately 1500 in-patients per year. Over the last 5 years, we have been publishing approximately 20 original research papers every year. The most important publication with 100+ citations include our work on designing the disease assessment instrument for takayasu’s arteritis namely the ITAS (Indian Takayasu’s Arteritis Score) 2010 and ITAS-A score.
I started a two year Post-Doctoral Clinical Fellowship training and Medical Council of India approved 3 year DM programme under the Tamil Nadu Dr.MGR Medical University, Chennai. All the current faculty at CMC, Vellore are my students. The department was also recognized by the National Board of Examinations for DNB training in rheumatology. The department is also recognized by the Tamil Nadu Dr.MGR Medical University for Ph.D programme and I am the only recognized guide for this purpose in the department.
I have conducted the Annual Conference of Indian Rheumatology Association at our centre in 2011 and the meeting was the first in the history of Indian rheumatology to have the President of the American College of Rheumatology as our guest faculty and since then this tradition is continuing.
I am currently the President of the Indian Rheumatology Association and have initiated several new initiatives for the cause of Indian Rheumatology including formation of the education cell, Indian College of Rheumatology, research cell, patient cell, database cell, legal and ethic cell, media and communication cell etc.
We are now aiming for a nationwide 2 year Post- Doctoral fellowship programme to meet the demand of shortage of rheumatologists in the country.
I am also the President-elect of the Asia-Pacific League of Associations for Rheumatology (APLAR) after serving one term each as Vice-President and Treasurer.
I have served 2 terms as Editor-In-Chief of International Journal of Rheumatic Diseases (IJRD) from 2012 to 2018 and was instrumental in bringing up the impact factor of the journal from 0.7 to 2.5.
My vision for future include studying traditional systems of medicines, creating affordable and primary care rheumatology access for common man and relevant translational and clinical research to improve quality of life for patients with rheumatic diseases in India as well as in other economically lesser privileged populations of the world.
Dr. Laniyati Hamijoyo is a rheumatology consultant in Internal Medicine Department, Faculty of Medicine University of Padjadjaran Bandung, Indonesia. She completed her fellowship training in Rheumatology at the University of Santo Tomas (UST) Hospital, Manila, Philippines.
She is a member of Asia Pacific Lupus Collaboration (APLC), Lupus special interest group (SIG) of Asia Pacific League of Associations for Rheumatology (APLAR) and Indonesia Rheumatology Association (IRA), and also served as scientific committee of APLAR (2016-2018). She actively involves in several national or international clinical trials. She has done several studies, been author and co-author of several journals and books. She is also actively involved in medical education, physician supervision and lay education programs.
Prof. Rohini Handa is currently Senior Consultant Rheumatologist at the Apollo Hospitals, New Delhi, India. He has earlier served on the faculty of the All India Institute of Medical Sciences for over two decades. Prof. Handa is the Dean of the Indian College of Physicians. He has served as President of APLAR (Asia Pacific League of Associations for Rheumatology) and as the Chair of ILAR (International League of Associations for Rheumatology) in 2012. He was the President of the Indian Rheumatology Association from 2009-2011. He has authored/co-authored more than 335 papers, book chapters, review articles and abstracts in national and international journals.
Dr. SA Haq, Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU) established the first Rheumatology Clinic of the country in October 1991. He was one of the co-founders of Bangladesh Rheumatology Society in 1997 and now is its Senior Vice President. In June 2000, as Chief Investigator, he founded the COPCORD Study Group in Bangladesh. The group has completed stage I COPCORD study and is carrying out stage II and III activities. He became Professor of Medicine (Rheumatology) in July 2001and Professor of Rheumatology in July 2006. He was awarded Fellowship of the Royal College of Physicians of Edinburgh in 2003 and International Fellowship of the American College of Rheumatology in 2005. Dr. Haq’s areas of academic interest include Epidemiology of rheumatic disorders, knee OA and SLE. He has 160 publications in local and international journals out of which 85 are originals. He was awarded a Gold Medal by “Bangladesh Academy of Sciences” for contribution to the advancement of Science in the country. He has served Asia-Pacific League of Associations for Rheumatology (APLAR) in the capacities of APLAR-COPCORD (Community Oriented Program for Control of Rheumatic Disorders) coordinator, Vice President and Treasurer. Currently, Dr. Haq is holding the positions of President Elect of APLAR.
Dr. Graeme Jones attended Sydney University graduating with first class honours in Medicine in 1985. He then did training in Internal Medicine and Rheumatology in Sydney and Newcastle. He became a fellow of the Royal Australasian College of Physicians in 1991. While at Newcastle he also did a Masters degree in Clinical Epidemiology. He then moved to the Garvan Institute in Sydney where he completed a doctorate in Osteoporosis Epidemiology in 1994. He is also a fellow of the Australian faculty of Public Health Medicine. Since 1995 he has been in Hobart, Tasmania where he combines clinical practice and research. He is currently Professor of Rheumatology and Epidemiology and Head of the Musculoskeletal Unit at the Menzies Research Institute as well as Head of the Department of Rheumatology at Royal Hobart Hospital. An NHMRC Practitioner Fellowship funds his position. He is also the current Medical Director of the Arthritis Foundation of Australia. He has received grants from competitive and non-competitive sources totalling over $16 million dollars and has published >250 articles primarily on the epidemiology of osteoporosis and osteoarthritis. In more recent years he has concentrated on both industry sponsored and investigator initiated clinical trials. He has received awards and given numerous oral presentations at the annual scientific meetings of the American Society for Bone and Mineral Research, the American College of Rheumatology, OARSI and EULAR. His current research interests are the development of peak bone mass and fracture aetiology in children, genetic and environmental risk factors for osteoarthritis, health promotion, the role of environmental factors such as diet and physical activity in osteoporosis and fractures in the elderly, clinical trials and meta-analysis.
Dr. Mohit Kapoor is the Director of the Arthritis Research Program (the largest multidisciplinary Arthritis Research Program in Canada) at the Krembil Research Institute and Toronto Western Hospital, University Health Network (Toronto), where he is directing basic, clinical, and translational research in multiple arthritis diseases. He is also the Director of Cartilage Biology and Joint Restoration Therapeutics within the Arthritis Program at the University Health Network. Dr. Kapoor’s translational research program is directed towards: (1) Understanding the complex cellular and molecular mechanisms associated with joint destruction during osteoarthritis; (2) Identifying reliable biomarkers for early identification of patients with osteoarthritis to enable early intervention; (3) Identifying novel therapeutic targets to stop/delay osteoarthritis and restore joint function. His research is funded by various research organizations including the Canadian Institute of Health Research (CIHR), Canadian Foundation for Innovation (CFI), Natural Sciences and Engineering Research Council of Canada (NSERC), Krembil Foundation, The Arthritis Society, Stem Cell Network, etc. He also sits on review panels & boards of various research/funding organizations across the globe.
Professor CS Lau is Chair and Daniel CK Yu Professor in Rheumatology and Clinical Immunology of the Department of Medicine, the University of Hong Kong. He is also Associate Dean (Teaching & Learning) and Director of the Bau Institute of Medical and Health Sciences Education of the Li Ka Shing Faculty of Medicine, the University of Hong Kong, as well as President of the Hong Kong Academy of Medicine. Professor Lau is currently Guest Professor of the Central South University and Honorary Professor of the Peking Union Medical College Hospital of China.
Professor Lau has made significant contribution to the development of Rheumatology locally and internationally. He is Honorary Consultant and Chief of the Division of Rheumatology and Clinical Immunology, which was voted APLAR Center of Excellence in 2016, at Queen Mary Hospital. Professor Lau was also President of the Hong Kong Society of Rheumatology (1997-2001), Chairman of the Subspecialty Board in Rheumatology/Immunology & Allergy of the Hong Kong College of Physicians (2001-2007) and Founding Chairman of the Hong Kong Arthritis & Rheumatism Foundation (2001). Regionally, he co-founded the Hong Kong-Guangzhou Rheumatology Study Group (1998), Huaxia Congress on Diagnosis and Management of Rheumatic Diseases (1999), Asian Congress of Autoimmunity (2005), Ten Topics in Rheumatology in Asia (2008) and the Asia Pacific Lupus Collaboration (2012). Between 2006 and 2008, Professor Lau was President of APLAR (Asia Pacific League of Associations of Rheumatology). He was instrumental in facilitating the success of indexing APLAR’s own journal – the International Journal of Rheumatic Diseases, in PubMed. In 2015, he led the development of APLAR’s first ever treatment recommendations for rheumatoid arthritis.
Professor Lau received his MBChB degree and MD with Honours from the University of Dundee. He is a Fellow of the Royal Colleges of Physicians of Edinburgh, Glasgow and London, as well as the Hong Kong College of Physicians and Hong Kong Academy of Medicine. He is Honorary Fellow of the Academy of Medicine Singapore, American College of Physicians, College of Physicians Singapore and Royal College of Physicians of Thailand.
Zhanguo Li, MD, PhD
Professor of Rheumatology, Chief, Department of Rheumatology and Immunity
Director, Center of Clinical Immunology
Director, Institute of Rheumatology and Immunology
Peking University Medical School, Beijing, China
Professor Li is currently the President of Clinical Immunology Association of China, the Honorary President of Chinese Rheumatology Association (CRA), the Past President of Asian and Pacific League Against Rheumatism (APLAR). He is also the Past President of International League of Associations for Rheumatology (ILAR). He is Associate Editor of Clinical Rheumatology, and Associate Editor of International Journal of Rheumatic Disease, the Chief Editor of Chinese Journal of Rheumatology, and the Chief Editor of Chinese Journal of Clinical Immunology and Rheumatology. In addition, he serves on the editorial boards of Nat Rev Rheum, Ann Rheum Dis, Curr Opin Rheum, and Clin Exp Rheum. He has published over 500 articles on peer reviewed journals, including Nat Med, Nat Genet, Immunity, Cell H&M, Ann Internal Med, and Ann Rheum Dis. He has contributed as Chief-Editor or author to over 30 textbooks and book chapters in Rheumatology and Immunology.
His interests are immune therapy and mechanism of rheumatoid arthritis and systemic lupus erythematosus.
WORAWIT LOUTHRENOO, M.D.
1979 B.S. in Medical Sciences (First Class Honour, Gold medal)
Chiang Mai University, Chiang Mai, Thailand
1981 Doctor of Medicine (First Class Honour, Gold medal)
Chiang Mai University, Chiang Mai, ThailandPostgraduate training and fellowship appointment:
1981-1982 Rotating Intern, Chiang Mai University Hospital, Chiang Mai, Thailand
1982-1985 Medical Resident, Chiang Mai University Hospital, Chiang Mai, Thailand
1985-1986 Fellow in Rheumatology, Department of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
1988-1990 Fellow in Rheumatology, Department of Medicine, University of Pennsylvania School of Medicine and Veterans Administration Medical Center, Philadelphia, Pennsylvania, U.S.A.
1986 Instructor, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
1988 Assistant Professor of Medicine, Chiang Mai University, Chiang Mai, Thailand
1995 Associate Professor of Medicine, Chiang Mai University, Chiang Mai, Thailand
2000 Professor of Medicine, Chiang Mai University, Chiang Mai, Thailand
Chief, Division of Rheumatology, Chiang Mai University
Faculty Staff, Division of Rheumatology, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
1. President of the Thai Rheumatism Association, 2018-2020
2. Vice President of the Asia Pacific League of Association for Rheumatology, 2016-1018
3. Chairman of the Training Committee of the Department of Internal Medicine, Faculty of Medicine, Chiang Mai University
4. Chairman of the Training and Examination Committee of the Royal College of Physician of Thailand (Rheumatology)
1985 Diploma, Thai Board of Internal Medicine
1986 Certificate, Fellow in Rheumatology, Siriraj Hospital, Mahidol University, Bangkok, Thailand
1990 Certificate, Fellow in Rheumatology, University of Pennsylvania School of Medicine and Veterans Administration Medical Center, Philadelphia, Pennsylvania, U.S.A.
1994 Diploma, Thai Board of Rheumatology, The Royal College of Physician of Thailand
2005 Diploma, Thai Board of Rheumatology, Thai Medical Council
1. Best internist of the year 2010. The Royal College of Physician of Thailand.
2. Best researcher (Golden Elephant) award of the year 2011. Chiang Mai University, Thailand.
3. Best Alumni of the year 2012. Faculty of Medicine, Chiang Mai University, Thailand.
4. Best teacher of the year 2013. Faculty of Medicine, Chiang Mai University, Thailand.
5. Best senior researcher (Golden Elephant) award of the year 2015. Chiang Mai University, Thailand.
Membership in professional and scientific society:
1. Member of the Royal College of Physician of Thailand
2. Member of the Thai Medical Council
3. Member of the Thai Rehabilitation Association
4. Fellow of the American College of Rheumatology
5. Editor of the Chiang Mai Medical Bulletin
6. Editorial Board of the Royal College of Physician Bulletin
7. Editorial Board of the Internal Medicine Journal of Thailand
8. International Board of the Journal of Clinical Rheumatology
9. Editorial Board of the Siriraj Medical Journal
10. Associate Editor of the International Journal of Rheumatic Diseases
Kevin Pile is the Editor-in-Chief of the International Journal of Rheumatic Diseases and Director of Medicine at Campbelltown Hospital Sydney and Conjoint Professor of Medicine at Western Sydney University. He is a Past President of APLAR, having served previously as Secretary-General, and Treasurer; and a past Secretary of the Australian Rheumatology Association. He is a graduate of the University of Otago, who completed his MD research at the University of Oxford. He has held senior academic positions in the University of Adelaide and James Cook University. Recent research activities relate to quality of life in gout patients and pharmacokinetic studies of febuxostat with varying renal function.
Dr. Jean-Pierre Raynauld obtained his medical degree at the University of Montreal (Montreal, Quebec, Canada) in 1983 and was appointed at the Department of Medicine at the University of Montreal in 1996. He completed his training in Clinical Rheumatology at the University of Montreal in 1989 and a Post-Doctoral Fellowship in Clinical Epidemiology, in the Division of Immunology and Rheumatology, at Stanford University in California, USA from 1990 to 1993. He is a Fellow in Internal Medicine and in Rheumatology of the Royal College of Physicians of Canada and is certified by the American Board of Internal Medicine and Rheumatology.Doctor Raynauld is an expert in the field of clinical research in osteoarthritis. He is Head of the Osteoarthritis Clinical Research Unit at the Montreal Rheumatology Institute affiliated with the University of Montreal Hospital Centre (CHUM). He was formerly vice-president of the Royal College of Physician Examination Board (rheumatology) and sits as President of the Canadian Laurentian Conference of Rheumatology. He was recently member of the Editorial Board of the Osteoarthritis and Cartilage journal.Doctor Raynauld’s research interests focus on the evaluation of the progression of osteoarthritis using magnetic resonance imaging (MRI). He is also interested in evaluating intra-articular approaches to the treatment of osteoarthritis. He has participated as principal investigator or co-investigator in several studies addressing clinical outcomes using intra-articular viscosupplements and corticosteroids, as well as having conducted studies using MRI technology to evaluate oral medications such as bisphosphonates, strontium ralenate, chondroitin sulfate, and other inhibitors of cartilage degradation in patients with knee osteoarthritis. He has published more than 75 original articles related to osteoarthritis and has presented at numerous meetings in North America.
Yeong-Wook Song, MD, PhD
Yeong-Wook Song is Professor of Internal Medicine at the Seoul National University, College of Medicine, where he has been since 1988. Dr. Song received his medical degree from Seoul National University College of Medicine. His fellowship training in rheumatology was at University of California Los Angeles under the direction of Bevra Hahn. He was authored over 200 articles published in peer-reviewed journals. He is a fellow of the American College of Rheumatology, a former local Secretary General of Asia Pacific League against Rheumatism 2004, President of East Asian Group of Rheumatology, and a Chairman of the Board, Korean College Rheumatology. Currently he serves as a chairman of scientific committee of Asia Pacific League against Rheumatism; Vice Chairman of the Board, Korean Association of Internal Medicine. Dr. Song’s current research is on the genetics, pathogenesis and biomarkers of lupus, rheumatoid arthritis and myositis. He also provides consultations and long-term care for patients with rheumatic diseases. Among his awards are the Ellis-Dressner Award of the Southern California Chapter of the Arthritis Foundation and Young Investigator Award from Seoul National University Hospital.
TSUTOMU TAKEUCHI, M.D., Ph.D.PRESENT
Division of Rheumatology,
Department of Internal Medicine,
Keio University School of Medicine
Professor of Internal Medicine,
Chief of Rheumatology,
Vice dean, Keio University School of Medicine (October, 2011~Semptember, 2013)
General Director of Keio University Hospital
(October 1st, 2013~present)Keio University School of Medicine
35 Shinanomachi, SHINJYUKU,
TOKYO 160-8582, JAPANEDUCATION
Keio University, Faculty of Medicine, MD 1980
Keio University, Faculty of Medicine, PhD 1984TRAINING
INTERNSHIP & RESIDENCES
1980-1983: Resident on Internal Medicine, Keio University HospitalRESEARCH FELLOWSHIP
1980-1984: Clinical and research fellow, Division of Rheumatology and Clinical Immunology, Keio University
1985-1986: Research Fellow, Tumor Immunology
(Prof. Stuart F. Schlossman), Dana-Farber Cancer InstituteACADEMIC APOINTMENTS
1984-1985: Research associate, Rheumatology/Clinical Immunology, Keio University Faculty of Medicine
1986-1988: Associate of Medicine, Saitama Medical University
1989-1992: Assistant Professor of Medicine, Saitama Medical University
1993-1998: Associate Professor of Medicine, Saitama Medical University
1998-2009: Professor of Medicine, Saitama Medical University
2004-2009: Vice dean of Saitama Medical University
2009-present: Professor of Rheumatology, Department of Internal Medicine, Keio University School of Medicine
October, 2011-September, 2013: The assistant dean, Keio University School of Medicine
0ctober, 2013~present: General Director, Keio University Hospital
August, 2014~September, 2015: Chief of Clinical and Translational Research Center, Keio University HospitalOTHER PROFESSIONAL POSITIONS
1992-: Visiting Assistant professor of Medicine, Tokyo
1993-1995: Visiting Associate Professor of Medical Research Institute, Tokyo Medical and Dental University
1996-2009: Visiting Assistant professor of Medicine, Keio University, School of Medicine
2009-present: Visiting Professor of Medicine, Saitama Medical University
Dr Linda Kurniaty Wijaya SpPD KR
Linda is an Internist Consultant Rheumatologist in Jakarta Indonesia practice for 12 years. Currently she is in private practice in Premier Bintaro Ramsay Sime Darby Hospital.
Dr Linda received her basic medical training at University of Padjadjaran, and continuing to Internal Medicine and Rheumatologist at Indonesia University and graduated in 2006. She served as consultant physician at division of Rheumatology Department of Internal Medicine University of Indonesia-RSCM before leaving for private practice.
Dr Linda is an active member of Indonesia Society of Rheumatology and Asia Pacific League of Associations for Rheumatology. She is also one of APLAR Working Group members on RA Recommendation. Her main interest is in the field of Lupus where she has done several studies.
Kazuhiko Yamamoto graduated from The University of Tokyo School of Medicine in 1977. After finishing his residency in internal medicine and rheumatology, he conducted basic research in Heidelberg. In 1997, he was promoted to be a professor and chairman of Department of Allergy and Rheumatology, The University of Tokyo. In 2017, he reached the mandatory retirement age of the University and moved to RIKEN Center for Integrative Medical Sciences as a deputy director. He is now planning to establish a research system of human immunology.
Dr Yeap is a Consultant Rheumatologist at Subang Jaya Medical Centre, Selangor, Malaysia. Her previous appointments include Associate Professor and Head of the Rheumatology Unit at the Department of Medicine, University Malaya.
She is the current Vice-President of the Malaysian Osteoporosis Society and its Immediate Past President, a Past President of the Malaysian Society of Rheumatology, and was previously a Vice-President of the Asia-Pacific League of Associations for Rheumatology (APLAR).
Her research interests focus on osteoporosis, rheumatoid arthritis and systemic lupus erythematosus.